Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 95.49B | 95.49B | 90.57B | 83.84B | 81.49B | 69.97B |
Gross Profit | 15.57B | 15.57B | 14.36B | 12.63B | 12.29B | 6.96B |
EBITDA | 8.31B | 11.83B | 9.79B | 7.56B | 8.02B | 2.73B |
Net Income | 3.79B | 3.79B | 3.85B | 1.59B | 2.79B | -1.87B |
Balance Sheet | ||||||
Total Assets | 148.54B | 148.54B | 131.61B | 114.57B | 104.86B | 96.50B |
Cash, Cash Equivalents and Short-Term Investments | 22.19B | 22.19B | 25.34B | 23.60B | 15.88B | 17.47B |
Total Debt | 44.23B | 44.23B | 37.40B | 38.05B | 29.90B | 26.13B |
Total Liabilities | 67.11B | 67.11B | 58.69B | 55.79B | 50.40B | 44.98B |
Stockholders Equity | 79.11B | 79.11B | 70.81B | 56.85B | 52.72B | 48.04B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -9.21B | -6.53B | -520.00M | -3.77B | -364.00M |
Operating Cash Flow | 0.00 | 9.06B | 9.44B | 6.25B | 2.48B | 3.42B |
Investing Cash Flow | 0.00 | -18.75B | -14.21B | -6.60B | -6.11B | -3.19B |
Financing Cash Flow | 0.00 | 4.70B | 5.38B | 6.91B | 1.57B | 1.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥256.80B | 16.37 | 13.79% | 0.76% | 15.13% | 31.79% | |
75 Outperform | ¥181.68B | 13.28 | 15.87% | 1.91% | 9.11% | 114.88% | |
75 Outperform | ¥109.98B | 36.41 | 10.16% | 2.11% | 4.48% | -39.40% | |
70 Outperform | ¥100.93B | 19.10 | 4.84% | 2.35% | -2.07% | -18.83% | |
68 Neutral | ¥84.61B | 14.32 | ― | 3.23% | 7.11% | 7.49% | |
66 Neutral | ¥23.60B | 10.22 | ― | 5.71% | 3.34% | -57.23% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
CMK Corporation has announced a merger with its wholly owned subsidiary, CMK PRODUCTS Corporation, effective April 1, 2026. This strategic move is aimed at enhancing the company’s overall strength, improving business competitiveness, and increasing management efficiency by combining mass production capabilities with short delivery prototype expertise.
The most recent analyst rating on (JP:6958) stock is a Buy with a Yen395.00 price target. To see the full list of analyst forecasts on CMK Corporation stock, see the JP:6958 Stock Forecast page.
CMK Corporation has successfully completed the payment process for issuing new shares as restricted stock compensation, a move initially announced on July 18, 2025. This issuance involves 41,624 common shares at a price of 339 yen per share, totaling 14,110,536 yen, and is allocated to six company directors, excluding outside directors, which may enhance executive alignment with shareholder interests.
CMK Corporation reported a challenging first quarter for the fiscal year 2025, with significant declines in key financial metrics compared to the previous year. Net sales slightly decreased by 0.4%, while operating income and ordinary income saw drastic reductions of 78.6% and 89.4%, respectively. The company’s profit attributable to owners of the parent plummeted by 94.4%. The equity ratio remained stable at around 52.8%, but comprehensive income turned negative. Despite these setbacks, CMK Corporation maintains its financial forecast for the year ending March 31, 2026, with a slight increase in net sales expected.
CMK Corporation has announced the issuance of new shares as part of a restricted stock compensation plan for its directors, excluding outside directors. This initiative aims to incentivize directors to enhance corporate value and align their interests with shareholders. The issuance involves 41,624 common shares at an issue price of 339 yen per share, totaling 14,110,536 yen. The transfer restrictions on these shares will be lifted under certain conditions related to the directors’ tenure, promoting long-term engagement and stability within the company’s leadership.